Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib.
Daemen, Anneleen; Wolf, Denise; Korkola, James; Griffith, Obi; Frankum, Jessica; Brough, Rachel; Jakkula, Lakshmi; Wang, Nicholas; Natrajan, Rachael; Reis-Filho, Jorge; Lord, Christopher; Ashworth, Alan; Spellman, Paul; Gray, Joe; Veer, Laura; Breast Cancer Research & Treatment, 2012, vol. 135, issue 2, p 505, ISSN 01676806. ISBN 01676806.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef